Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.32 |
| ▸ | PIM1 | P11309 | 2/20 | 0.31 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.31 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.31 |
| ▸ | PLK4 | O00444 | 1/20 | 0.31 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | CHUK | O15111 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | INSR | P06213 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | PRKACA | P17612 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6070098 | 0.71 | L3MBTL1 (0.41) | TGFBR1MAPK10ROCK2CDK2TYK2 | |
| SCHEMBL1625393 | 0.64 | — | — | |
| SCHEMBL4325442 | 0.64 | IDO1 (0.37) | ALDH1A1CSNK1A1CLK4 | |
| SCHEMBL27751556 | 0.64 | IDO1 (0.37) | ALDH1A1CSNK1A1CLK4 | |
| Hydrochloric Acid SCHEMBL5047885 | 0.63 | IDO1 (0.36) | ALDH1A1NPSR1CSNK1A1CLK4 | |
| SCHEMBL671939 | 0.62 | — | — | |
| SCHEMBL22999206 | 0.61 | ATR (0.38) | CYP4F2CYP4A11PIM1ADORA2AADORA1 | |
| SCHEMBL23019617 | 0.61 | ATR (0.38) | CYP4F2CYP4A11PIM1KDRLTA4H | |
| SCHEMBL30186063 | 0.60 | PDE4A (0.40) | LRRK2CHEK1ALDH1A1CSNK1A1CLK4 | |
| SCHEMBL11272209 | 0.60 | TRPA1 (0.42) | PTGESLRRK2PIM1PLK4FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169654-A1 | New Organic Compounds | SERVIER PHARMACEUTICALS LLC (US) | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169654-A1 | New Organic Compounds | MNAT1, MAT2A, EIF4A2 | CYP4F2 1228/4885CYP4A11 2580/4885TGFBR1 3948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.